Event

Stanley J. Szefler

MD
Children's Hospital Colorado;Children's Hospital Colorado and University of Colorado School of Medicine;Children's Hospital Colorado/University of Colorado School of Medicine;Children's Hospital of Co

Benjamin Ortiz

MD
Novartis Pharmaceuticals Corp.;Novartis Pharmaceuticals Corporation

Aimee Foreman

PhD
ICON Biostatistics & Programming

Eugene R. Bleecker

MD
University of Arizona;University of Arizona College of Medicine;University of Arizona Health Sciences

Evgueni Neiman

PhD
ICON Biostatistics & Programming

Farid Kianifard

PhD
Novartis Pharmaceuticals Corporation

Bradley E. Chipps

MD
American College of Allergy, Asthma & Immunology;Capital Allergy;Capital Allergy and Respiratory Disease Center

Tmirah Haselkorn

PhD
EpiMetrix Inc.

Robert S. Zeiger

M.D.
Kaiser Permanente;Kaiser Permanente Southern California Region

Natural History of TENOR I Patients More than a Decade Later in TENOR II Based on GOLD Classification of Severity of Airflow Obstruction